5-40964750-A-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000587.4(C7):āc.1759A>Cā(p.Thr587Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.235 in 1,611,870 control chromosomes in the GnomAD database, including 47,050 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_000587.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C7 | NM_000587.4 | c.1759A>C | p.Thr587Pro | missense_variant | 14/18 | ENST00000313164.10 | NP_000578.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C7 | ENST00000313164.10 | c.1759A>C | p.Thr587Pro | missense_variant | 14/18 | 1 | NM_000587.4 | ENSP00000322061 | P1 |
Frequencies
GnomAD3 genomes AF: 0.194 AC: 29525AN: 152074Hom.: 3475 Cov.: 32
GnomAD3 exomes AF: 0.240 AC: 59740AN: 248552Hom.: 7842 AF XY: 0.250 AC XY: 33752AN XY: 134830
GnomAD4 exome AF: 0.239 AC: 348979AN: 1459678Hom.: 43574 Cov.: 31 AF XY: 0.244 AC XY: 177151AN XY: 726174
GnomAD4 genome AF: 0.194 AC: 29543AN: 152192Hom.: 3476 Cov.: 32 AF XY: 0.199 AC XY: 14805AN XY: 74400
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
Likely benign, no assertion criteria provided | clinical testing | Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ | - | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at